Timolol Eye Drops in the Treatment of Acute Migraine Headache
Sponsor: Truman Medical Center
Terminated
Unable to enroll sufficient participants
A NA clinical study on Migraine, this trial is terminated or withdrawn. The trial is conducted by Truman Medical Center and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2017 — May 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Truman Medical Center
- University of Missouri, Kansas City
For direct contact, visit the study record on ClinicalTrials.gov .